The call for abstracts for ASM Microbe 2017 will open early-November 2016, and close early-January 2017. Don’t miss this great opportunity to present your latest research findings at this unprecedented event!
In order to create an innovative and comprehensive program that reflects the broad scope of the microbial sciences, the Program Committee has developed seven tracks. Please take a moment to review the list of tracks.
Abstract submission opens: November 1, 2016
Travel award application opens: Early-November 2016
Abstract submission closes: January 9, 2017
Travel award application closes: Early-January 2017
Abstract dispositions emailed: Mid-February 2017
Abstract withdrawal deadline: Late-February 2017
Late-breaker abstract submission opens: Early-February 2017
Late-breaker abstract submission deadline: Early-March 2017
Late-breaker abstract withdrawal deadline: Late-March 2017
Late-breaker abstract dispositions emailed: Late-March 2017
Abstract Submission Guidelines and Criteria
General Abstract Guidelines
- Abstracts must be well written and easy to understand.
- Approval of all co-authors must be obtained before placing their names on an abstract.
- Submission of multiple overlapping abstracts is discouraged.
- The reason for the study or how the study came about (e.g., hypothesis, discovery or central question) should be clearly stated.
- Methods must be included.
- Data must be objectively gathered, analyzed and reported. Sample size should be adequate for the study, and where indicated, statistical evaluation should be included.
- Data must support the stated conclusion(s).
- It is preferred that ASM Microbe 2017 be the first major presentation of the abstract.
- A presenter may be a presenter on more than one abstract.
- Programming decisions are considered final.
- All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s) to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation.
Examples of abstracts that may be rejected
- Abstracts that are general descriptions of a new product.
- Abstracts that read like advertisements.
- Abstracts that are a general description of a managerial innovation.
- Case reports (unless truly remarkable).
In consideration of ASM’s acceptance of the abstract and any other materials that attendee may submit to ASM in connection with an ASM meeting or conference (the “Presentation Materials”), attendee grants ASM a royalty-free, nonexclusive worldwide license to use, modify, publish, reproduce, prepare derivative works, distribute, publicly display, and archive the Presentation Materials, in whole or in part, in all forms of print and electronic media, for commercial or noncommercial use. Under this license, attendee also grants ASM permission to sublicense to others any or all of the aforementioned rights.
Attendee understands that he/she retains ownership of the Presentation Materials; however, attendee further understands that ASM shall own and retain all intellectual property rights in any printed or electronic collection or compilation of Presentation Materials in whole or in part.
By submitting the Presentation Materials, attendee represents and warrants that the Presentation Materials are original to attendee or that he/she has the right to use such Presentation Materials, and that the Presentation Materials do not contain any material that will violate the copyright or any personal, proprietary, or other right of any person or entity. Attendee is responsible for obtaining any necessary permissions required to grant rights to ASM prior to submission.
ASM acknowledges that no copyright protection attaches to Presentation Materials that were authored by U.S. Government Employees, so the abstract license does not apply in those situations. However, all other provisions that attendee is required to agree to during the abstract submission process remain in effect.
Plagiarism will not be tolerated in submitted abstracts. All submitted abstracts identified with plagiarism will be sent to the Program Committee for review and handling.
The NIH ORI publication "Avoiding Plagiarism, Self-Plagiarism, and Other Questionable Writing Practices: a Guide to Ethical Writing" can help authors identify questionable writing practices.